GSK Scientists Knew About Zantac's Cancer Risks For Forty Years

By Herman James / February 20, 2023 / marketsanity.com / Article Link

Zero Hedge, Released on 2/20/23

Three years after the Food & Drug Administration (FDA) pulled GSK Plc's heartburn drug Zantac off the market due to suspected links to cancer, and just two weeks before the trial

Continue...

GSK Scientists Knew About Zantac's Cancer Risks For Forty Years added by Herman James on 02/20/2023View all posts by Herman James ?+'

Recent News

Thor Explorations continues to lead TSXV global gold producers

June 02, 2025 / www.canadianminingreport.com

Gold stocks rise with juniors outperforming majors

June 02, 2025 / www.canadianminingreport.com

Gold Becomes Largest Metals Market

May 26, 2025 / www.canadianminingreport.com

Gold stocks surge on metal gain, Amex boosts Perron resource

May 26, 2025 / www.canadianminingreport.com

Global trade tensions ease and inflation continues to decline

May 19, 2025 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok